限制性股票激励计划
Search documents
澄星股份: 江苏澄星磷化工股份有限公司监事会关于公司2025年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-08-08 16:23
Core Viewpoint - Jiangsu Chengxing Phosphate Chemical Co., Ltd. has announced the public disclosure and verification opinions regarding the list of incentive objects for its 2025 restricted stock incentive plan, ensuring compliance with relevant regulations and confirming the legitimacy of the proposed recipients [1][2][3] Group 1: Public Disclosure of Incentive Objects - The company publicly announced the draft of the 2025 restricted stock incentive plan and the list of proposed incentive objects on the Shanghai Stock Exchange website [1] - The internal public disclosure of the proposed incentive objects took place from July 30, 2025, to August 8, 2025, lasting a total of 10 days, during which no objections were raised by employees [2] Group 2: Verification by the Supervisory Board - The supervisory board verified the list of proposed incentive objects, including their identity documents, employment contracts, and positions held within the company [2] - The supervisory board concluded that the proposed incentive objects meet the qualifications set forth in the relevant regulations and that the information provided is accurate and not misleading [3] Group 3: Eligibility of Incentive Objects - The proposed incentive objects include current directors, senior management, core management, key personnel, and outstanding high-potential employees [3] - The incentive plan excludes independent directors, supervisors, and shareholders or actual controllers holding more than 5% of the company's shares [3]
银禧科技: 第六届董事会第十九次会议决议公告
Zheng Quan Zhi Xing· 2025-08-08 16:23
Core Viewpoint - The company has successfully passed several key resolutions during its board meetings, including the approval of its 2025 semi-annual report and the initiation of a stock incentive plan, which reflects its commitment to transparency and growth strategies [1][2][3] Group 1: Financial Reporting - The board approved the 2025 semi-annual report, which is deemed to accurately reflect the company's financial status and operational results, with a unanimous vote of 9 in favor [1] - The report is stated to contain truthful, accurate, and complete information without any misleading statements or significant omissions [1] Group 2: Stock Incentive Plan - The board approved the first unlock conditions of the 2024 stock incentive plan, allowing for the release of 5.56 million shares, which is 1.16% of the total share capital of 479,538,185 shares [1] - The plan involves 47 eligible participants who will benefit from the first unlock of restricted stock [1] Group 3: Capital Increase and Related Transactions - The company plans to increase capital in its subsidiary, Dongguan Yinxin Special Materials Technology Co., Ltd., with a total investment of 10.5 million yuan from the company and 4.5 million yuan from its affiliate, Dongguan Dexuan Technology Co., Ltd. [2] - This transaction is classified as a related party transaction due to the ownership structure of Dexuan Technology, which is controlled by a board member [2][3] - The board's approval for this transaction was unanimous, with 8 votes in favor, and it does not require further shareholder approval [3]
龙江交通: 北京市康达律师事务所关于黑龙江交通发展股份有限公司终止实施2021年限制性股票激励计划暨注销已回购用于激励计划股票的法律意见书
Zheng Quan Zhi Xing· 2025-08-08 16:23
Core Viewpoint - Heilongjiang Transportation Development Co., Ltd. has decided to terminate its 2021 restricted stock incentive plan and cancel the repurchased shares intended for this plan due to market environment changes and difficulties in achieving the original performance targets [7][8]. Group 1: Termination and Cancellation Details - The company has obtained necessary approvals and authorizations for the termination and cancellation of the incentive plan, which includes the cancellation of 10,408,656 shares that were repurchased for the plan [7][9]. - The termination of the incentive plan was approved during the board meetings held on October 27, 2021, and August 8, 2025, where relevant proposals were passed [6][7]. - The cancellation of shares is in compliance with the relevant laws and regulations, and the company will continue to fulfill its disclosure obligations [9]. Group 2: Reasons for Termination - The decision to terminate the incentive plan is influenced by changes in market conditions and adjustments in the company's industrial structure, making it difficult to meet the original performance assessment criteria [8]. - The company is required to cancel the repurchased shares within three years as per regulations, which necessitates the cancellation of the shares used for the incentive plan [8]. Group 3: Impact on the Company - The termination of the incentive plan is not expected to have a negative impact on the company's financial status or the interests of shareholders, as the plan had not yet been implemented [8]. - The company's operational activities, financial condition, and future development are not anticipated to be significantly affected by this termination and share cancellation [8].
锦江酒店: 锦江酒店:上海荣正企业咨询服务(集团)股份有限公司关于上海锦江国际酒店股份有限公司2024年限制性股票激励计划预留授予相关事项之独立财务顾问报告
Zheng Quan Zhi Xing· 2025-08-08 16:23
Core Viewpoint - The report discusses the 2024 Restricted Stock Incentive Plan of Shanghai Jin Jiang International Hotel Co., Ltd., detailing the conditions for granting restricted stocks to eligible employees and the necessary approvals obtained for the plan [6][17]. Summary by Sections Definitions - The report defines key terms related to the incentive plan, including "restricted stock," "incentive objects," and "grant date," which are essential for understanding the plan's structure and conditions [2][3]. Approval and Authorization - The plan has been approved by the company's board and relevant authorities, including the Shanghai State-owned Assets Supervision and Administration Commission, ensuring compliance with legal and regulatory requirements [9][17]. Granting Conditions - The report outlines the conditions under which the restricted stocks can be granted, including performance metrics such as a minimum return on equity of 4.6% and a net profit growth rate of at least 20% for the year 2023 [10][16]. Granting Details - A total of 603.424 million shares of restricted stock are to be granted, with 91.38 million shares being the actual amount proposed for the current granting phase due to unmet performance targets in the first release period [9][10]. Vesting Schedule - The vesting schedule for the restricted stocks includes three phases, with the first phase allowing for 40% of the stocks to be released after 24 months, and subsequent phases releasing additional portions after 36 and 48 months [12][14]. Financial Impact - The report emphasizes the need for the company to account for the financial implications of the stock incentive plan, including potential dilution effects on existing shareholders [16]. Conclusion - The independent financial advisor concludes that the incentive plan has met all necessary conditions and approvals, aligning with the company's strategic goals and regulatory frameworks [17].
锦江酒店: 锦江酒店:北京市金杜律师事务所上海分所关于上海锦江国际酒店股份有限公司2024年限制性股票激励计划预留部分授予事项的法律意见书
Zheng Quan Zhi Xing· 2025-08-08 16:23
北京市金杜律师事务所上海分所 《中华人民共和国证券法》 (以下简称《证券法》)、 《上市 公司股权激励管理办法》(2025 修正)(以下简称《管理办法》)、国务院国有资产 监督管理委员会和财政部《国有控股上市公司(境内)实施股权激励试行办法》 (以 下简称《试行办法》)等法律、行政法规、部门规章及规范性文件(以下简称法律 法规)和《上海锦江国际酒店股份有限公司章程》 (以下简称《公司章程》)及《上 海锦江国际酒店股份有限公司 2024 年限制性股票激励计划(草案)》1(以下简称 《激励计划》 )的有关规定,就公司向激励对象授予预留部分限制性股票的相关事 项(以下简称"本次授予")出具本法律意见书。 为出具本法律意见书,本所依据《律师事务所从事证券法律业务管理办法》和 《律师事务所证券法律业务执业规则(试行)》等有关规定,收集了相关证据材料, 查阅了按规定需要查阅的文件以及本所认为必须查阅的其他文件。在公司保证提 供了本所为出具本法律意见书所要求公司提供的原始书面材料、副本材料、复印材 料、确认函或证明,提供给本所的文件和材料是真实、准确、完整和有效的,并无 任何隐瞒、虚假或重大遗漏之处,且文件材料为副本或复印 ...
锦江酒店: 锦江酒店关于向2024年限制性股票激励计划激励对象授予预留部分限制性股票的公告
Zheng Quan Zhi Xing· 2025-08-08 16:23
证券代码:600754/900934 证券简称:锦江酒店/锦江 B 股 公告编号:2025-044 上海锦江国际酒店股份有限公司 关于向 2024 年限制性股票激励计划 激励对象授予预留部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 限制性股票预留授予日:2025 年 8 月 8 日 ? 限制性股票预留授予数量:91.38 万股 ? 限制性股票预留授予价格:11.15 元/股 上海锦江国际酒店股份有限公司(以下简称"公司")于 2025 年 8 月 8 日 召开第十一届董事会第四次会议,审议通过了《关于向 2024 年限制性股票激励 计划激励对象授予预留部分限制性股票的议案》,董事会认为《上海锦江国际酒 店股份有限公司 2024 年限制性股票激励计划(草案)》(以下简称"《激励计 划》")规定的预留部分限制性股票授予条件已经成就,根据公司 2024 年第一 次临时股东大会授权,确定限制性股票的预留授予日为 2025 年 8 月 8 日,现将 有关事项说明如下: 一、限制性股票授予情况 ...
锦江酒店: 锦江酒店2024年限制性股票激励计划预留授予激励对象名单
Zheng Quan Zhi Xing· 2025-08-08 16:23
上海锦江国际酒店股份有限公司 一、董事、高级管理人员(1 人) 钱康(副总裁) 二、中层管理及核心骨干人员(116 人) 序号 姓名 序号 姓名 序号 姓名 注:以上激励对象名单排名不分先后。 上海锦江国际酒店股份有限公司 ...
奥泰生物: 第三届董事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-08 16:11
Group 1 - The board of directors of Hangzhou Aotai Biotechnology Co., Ltd. held its 14th meeting of the third session on August 8, 2025, to discuss and vote on various proposals [1][2] - The board proposed to adjust the grant price of the 2022 Restricted Stock Incentive Plan from 25.0725 yuan per share to 23.5992 yuan per share, with a unanimous vote of 4 in favor [2][3] - The board approved the vesting of restricted stocks for 94 eligible incentive objects, totaling 409,472 shares, and for 18 reserved incentive objects, totaling 29,418 shares, based on the fulfillment of vesting conditions [2][3] Group 2 - The board decided to cancel 6,177 shares of restricted stock that were granted but not vested due to three incentive objects leaving the company [3][5] - All proposals discussed in the meeting were approved with no votes against or abstentions, indicating strong support from the board members [2][3]
奥泰生物: 监事会关于公司2022年限制性股票激励计划首次授予第三个归属期及预留授予第二个归属期归属名单的核查意见
Zheng Quan Zhi Xing· 2025-08-08 16:11
Core Points - The Supervisory Board of Hangzhou Aotai Biotechnology Co., Ltd. has reviewed and approved the list of beneficiaries for the third vesting period of the 2022 restricted stock incentive plan and the second vesting period of the reserved grant [1][2] - A total of 94 beneficiaries are proposed for the third vesting period and 18 beneficiaries for the second vesting period, all of whom meet the qualifications set forth in relevant laws and regulations [1][2] Summary by Sections - **Regulatory Compliance**: The incentive plan adheres to the Company Law, Securities Law, and other relevant regulations, confirming the legality and validity of the beneficiaries' qualifications [1] - **Beneficiary Eligibility**: The proposed beneficiaries for both vesting periods fulfill the conditions outlined in the incentive plan draft and are deemed eligible to receive restricted stock [1] - **Approval Process**: The Supervisory Board has formally agreed to the beneficiary list for the incentive plan, indicating a structured approval process [2]
奥泰生物: 第三届监事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-08-08 16:11
Meeting Overview - The third supervisory board meeting of Hangzhou Aotai Biotechnology Co., Ltd. was held on August 8, 2025, with a legal and valid resolution [1] Adjustment of Stock Incentive Plan - The supervisory board approved the adjustment of the grant price for the 2022 Restricted Stock Incentive Plan, in compliance with relevant laws and regulations, ensuring no harm to the company and all shareholders [2][3] - The voting results for the proposal showed 3 votes in favor, 0 against, and 0 abstentions [2] Vesting Conditions - The vesting conditions for the first grant of the third vesting period and the reserved grant of the second vesting period have been met, allowing 94 eligible incentive recipients to vest a total of 409,472 shares, and 18 reserved recipients to vest 29,418 shares [2][3] - The voting results for this proposal also showed 3 votes in favor, 0 against, and 0 abstentions [3] Cancellation of Stock Grants - Due to the departure of 3 incentive recipients, a total of 6,177 shares of unvested restricted stock will be canceled, in accordance with relevant laws and the 2022 Incentive Plan [3] - The voting results for the cancellation proposal were 3 votes in favor, 0 against, and 0 abstentions [3]